Alterations in miRNA Expression and Their Role in the Pathogenesis of Cervical Cancer.

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Cervical cancer is a significant global health issue, with high incidence and mortality rates.
• High-risk Human Papillomavirus (HPV) infection is a primary driver of cervical cancer development.
• MicroRNAs (miRNAs) are crucial small non-coding RNAs that regulate gene expression and are implicated in various cellular processes.

Purpose of the Study:

• To investigate the specific microRNA (miRNA) expression alterations in cervical cancer.
• To analyze the biological significance and pathways affected by these miRNA changes, particularly in the context of HPV infection.

Main Methods:

• Transcriptome data from cervical cancer and normal tissues were analyzed using GEO2R for differential miRNA and gene expression.
• Target genes for dysregulated miRNAs were predicted using the miRNA Pathway Dictionary Database.
• Biological pathway networks were constructed using Cytoscape, and associations with Hallmarks of Cancer were identified.

Main Results:

• Ten miRNAs and 82 target genes exhibited significantly altered expression in cervical cancer.
• These alterations affected 52 distinct biological pathways, including interferon signaling, interleukin signaling, and oxidative stress-induced senescence.
• Specific miRNAs like miR-106b-5p, miR-1183, miR-557, miR-15a-5p, and miR-21-5p were linked to pathways involved in cell cycle regulation, immune response, and P53 transcriptional regulation.

Conclusions:

• Dysregulated miRNA expression is a critical factor in cervical cancer pathogenesis.
• These miRNA alterations impact crucial biological pathways and Hallmarks of Cancer, including immune and cell cycle regulation.
• The study highlights the potential of miRNAs as diagnostic and prognostic biomarkers for cervical cancer, paving the way for improved therapeutic strategies.